Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1661 A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1662 Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia. Department of Clinical Pathology Prof. Mohamed Rafat / Mohammed Ibrahim Khalaf 2009
1663 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Radiotherapy and Nuclear medicine Prof. Mostafa El-Sayed Abdalones Mohamed 2009
1664 Evaluation of flow cytometric immunophenotyping and DNA analysis for detection of malignant cells in serosal cavity fluids. Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1665 Initial Results of Bladder Preserving Approach by Chemo-Radiotherapy in Patients with Muscle Invading Transitional Cell Carcinoma
 		Department of Radiotherapy and Nuclear medicine Prof. Mohammed Abdel-Hamid Ahmed Suleiman 2009
1666 Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.
 		Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2009
1667 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2009
1668 The role of platelets CD40 ligand (CD154) in acute coronary syndromes Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1669 Activation of nuclear factor kappa B and induction of migration inhibitory factor in tumors by surgical stress of laparotomy versus carbon dioxide pneumoperitoneum: an animal experiment Department of Surgical Oncology Dr. Anwar Tawfik Amin 2009
1670 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study Department of Pediatric Oncology Dr. Nasreen Mohamed Ali Khalifa 2008